| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000007096 |
| Receipt No. | R000008349 |
| Official scientific title of the study | A multicenter study of prognosis after the initiation of dialysis in patients with chronic kidney disease |
| Date of disclosure of the study information | 2012/01/18 |
| Last modified on | 2016/07/18 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | A multicenter study of prognosis after the initiation of dialysis in patients with chronic kidney disease | |
| Title of the study (Brief title) | Aichi cohort study of prognosis in patients newly initiated into dialysis (AICOPP) | |
| Region |
|
|
| Condition | ||
| Condition | Chronic kidney disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of AICOPP is to clarify a relationship between pre-dialysis management and prognosis after the initiation of dialysis in patients with chronic kidney disease |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | All-cause mortality after initiation of dialysis |
| Key secondary outcomes | 1) Cardiovascular events (admission due to heart failure, acute coronary syndrome, PCI, CABG, admission due to peripheral artery disease)
2) Admission due to infection |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All patients in chronic kidney disease:
1) aged 20 years and over, 2) newly initiated into dialysis |
|||
| Key exclusion criteria | All patients:
1) acute kidney injury, 2) death before discharge from hospital |
|||
| Target sample size | 1200 | |||
| Research contact person | |
| Name of lead principal investigator | Inaguma Daijo |
| Organization | Nagoya Daini Red Cross Hospital |
| Division name | Kidney Disease Center |
| Address | Myoken-cho 2-9, Showa-ku, Nagoya, Japan |
| TEL | 052-832-1121 |
| inaguma@nagoya2.jrc.or.jp | |
| Public contact | |
| Name of contact person | Inaguma Daijo |
| Organization | Nagoya Daini Red Cross Hospital |
| Division name | Kidney Disease Center |
| Address | Myoken-cho 2-9, Showa-ku, Nagoya, Japan |
| TEL | 052-832-1121 |
| Homepage URL | |
| inaguma@nagoya2.jrc.or.jp | |
| Sponsor | |
| Institute | Nagoya Daini Red Cross Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Aichi Jinzou Zaidan |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | prospective cohort study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000008349 |